Ruby Ray
Impact in
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
-
- Gastric Cancer Management and Outcomes
- Renal cell carcinoma treatment
- Lung Cancer Diagnosis and Treatment
Papers in
- Co-authors
- Gareth Owen Griffiths (8 shared papers)Tim Maughan (8 shared papers)Chris N Hurt (8 shared papers)Stephen J. Falk (8 shared papers)Somnath Mukherjee (7 shared papers)Rajarshi Roy (6 shared papers)John Bridgewater (4 shared papers)John Nicholas Staffurth (5 shared papers)
- Journals
- British Journal of Cancer (4 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)European Journal of Cancer (2 papers)The Lancet Oncology (2 papers)BMJ Open (1 paper)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Ruby Ray
13 papers receiving 884 citations
Ruby Ray's Hit Papers
Peers
Comparison fields: 5 of 71
- Oncology 413
- Pulmonary and Respiratory Medicine 276
- Surgery 351
- Cancer Research 90
- Gastroenterology 20
Countries citing papers authored by Ruby Ray
This map shows the geographic impact of Ruby Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruby Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruby Ray more than expected).
Fields of papers citing papers by Ruby Ray
This network shows the impact of papers produced by Ruby Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruby Ray. The network helps show where Ruby Ray may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruby Ray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial Hit paper breakdown → | 2013 | 315 |
| 2 | 2013 | 282 | |
| 3 | 2017 | 59 | |
| 4 | 2017 | 54 | |
| 5 | 2007 | 52 | |
| 6 | 2017 | 35 | |
| 7 | 2018 | 31 | |
| 8 | 2015 | 30 | |
| 9 | Plasma levels and clinical improvement--a comparative study of clomipramine and amitriptyline in depression. | 1980 | 18 |
| 10 | 2021 | 15 | |
| 11 | 2016 | 10 | |
| 12 | 2014 | 2 | |
| 13 | 2014 | 1 | |
| 14 | 2025 | 0 |
About Ruby Ray
Ruby Ray is a scholar working on Surgery, Oncology, Radiology, Nuclear Medicine and Imaging, Statistics, Probability and Uncertainty and Safety, Risk, Reliability and Quality, having authored 14 papers that have together received 904 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (7 papers), Pancreatic and Hepatic Oncology Research (2 papers), Radiomics and Machine Learning in Medical Imaging (2 papers), Thermochemical Biomass Conversion Processes (1 paper), Cancer Genomics and Diagnostics (1 paper), Neuroendocrine Tumor Research Advances (1 paper), Meta-analysis and systematic reviews (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Oncology (413 citations), Pulmonary and Respiratory Medicine (276 citations), Surgery (351 citations), Cancer Research (90 citations) and Gastroenterology (20 citations). Ruby Ray has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Gareth Owen Griffiths, Tim Maughan, Chris N Hurt, Stephen J. Falk, Somnath Mukherjee, Rajarshi Roy, John Bridgewater, John Nicholas Staffurth, Tom David Lewis Crosby and Simon Gollins. Their work appears in journals such as British Journal of Cancer, International Journal of Radiation Oncology*Biology*Physics, European Journal of Cancer, The Lancet Oncology and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.